A scientific team connected lung disease risk variants to their regulatory targets in disease-relevant cell types.
Determining activity of the mitotic stopwatch in individual cancer might help predict tumor response to treatment with anti-mitotic drugs, researchers suggest ...
An AI method offers a new way to understand protein structures in multiple dimensions and may be a useful tool for ...
Lonza's new offering provides manufacturing of spray-dried protein formulations, nucleotide-based drugs, and peptides.
On opening day of the 31 st annual Precision Med TRI-CON, hosted by Cambridge Healthtech Institute and held this week in San Diego, CA, Eric Topol, MD, renowned cardiologist and Director of the ...
Phase I/IIa data for a single dose of REGENEXBIO's gene therapy, RGX-314, shows promise for treating wet age-related macular degeneration.
Research from scientists at Albert Einstein College of Medicine, Northwestern University, and elsewhere indicates that forming long-term memories requires DNA damage and brain inflammation. The ...
Synthego announced that it will focus solely on the therapeutic applications of CRISPR while spinning off a new company, ...
A “can-do” attitude toward monoclonal antibody (mAb) production developed over the last 30 years has set the groundwork for ...
The elements needed to automate cell and gene therapy production are already available, they just need to be combined.
Step toward an HIV cure: a "shock and kill" virus-like particle shows promise as latency reversal agent in blood samples from ...
Genomic analysis reveals that viral host jumps from humans to other animals occur more frequently than from animals to humans ...